PharmaEngine, Inc. (4162.TWO)
TWD 87.4
(-1.58%)
TWD 87.4
(-1.58%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 256.97 Million | 202.01 Million | 929.67 Million | 64.76 Million | 16.07 Million | 745.22 Million |
| Net Income | 274.65 Million | 392.46 Million | 545.39 Million | 752.47 Million | 49.66 Million | 163.77 Million |
| Depreciation & Amortization | 9.02 Million | 8.61 Million | 10.26 Million | 12.55 Million | 6.7 Million | 2.92 Million |
| Deferred income taxes | -16.75 Million | - | -186.78 Million | -37.36 Million | 35.68 Million | -87.56 Million |
| Stock-based compensation | 3.38 Million | 2.36 Million | 89 Thousand | -1.05 Million | 5.83 Million | 15.24 Million |
| Change in working capital | 8.76 Million | -27.5 Million | 576.01 Million | -620.68 Million | -14.06 Million | 712.75 Million |
| Other non-cash items | -22.08 Million | -173.92 Million | -15.31 Million | -41.16 Million | -67.75 Million | -61.9 Million |
| Investing Cash Flow | -855.48 Million | -188.11 Million | -106.99 Million | 1.76 Billion | -18.5 Million | -600.95 Million |
| Investments in PPE | -958 Thousand | -3.94 Million | -229 Thousand | -608 Thousand | -208 Thousand | -510 Thousand |
| Acquisitions | - | - | - | 608 Thousand | - | 110 Thousand |
| Investment purchases | -1.73 Billion | -311.84 Million | -700 Million | -2.12 Billion | -3.32 Billion | -3.93 Billion |
| Sales/Maturities of investments | 880.21 Million | 127.86 Million | 595 Million | 3.89 Billion | 3.3 Billion | 3.32 Billion |
| Other Investing Activities | -40 Thousand | -195 Thousand | -1.76 Million | -679 Thousand | 5000.00 | 1.29 Million |
| Financing Cash Flow | -294.73 Million | -395.7 Million | -506.99 Million | -87.49 Million | -262.97 Million | -361.25 Million |
| Debt repayment | -7.53 Million | -7.99 Million | -9.59 Million | -491 Thousand | -660 Thousand | -73.64 Million |
| Dividends payments | -287.19 Million | -387.71 Million | -363.99 Million | -72.83 Million | -145.66 Million | -294.3 Million |
| Common Stock Repurchased | - | - | -133.41 Million | -3.84 Million | -125.51 Million | -73.64 Million |
| Common Stock Issuance | - | - | - | 491 Thousand | 11.89 Million | 6.7 Million |
| Other Financing Activities | -7.53 Million | -7.99 Million | -9.59 Million | -10.82 Million | -3.03 Million | 73.64 Million |
| Accounts receivables | -13.8 Million | 3.69 Million | 538.77 Million | -15.55 Million | 3.65 Million | 732.26 Million |
| Accounts payables | - | -3.69 Million | -538.77 Million | 15.55 Million | -20.08 Million | 20.08 Million |
| Inventory | 18.47 Million | -28.94 Million | 19.3 Million | -623 Thousand | -4.56 Million | -3.39 Million |
| Other working capital | 4.09 Million | 1.43 Million | 556.71 Million | -620.05 Million | 6.92 Million | 716.15 Million |
| Cash at beginning of period | 1.76 Billion | 2.15 Billion | 1.83 Billion | 92.77 Million | 358.34 Million | 575.36 Million |
| Cash at end of period | 875.61 Million | 1.76 Billion | 2.15 Billion | 1.83 Billion | 92.77 Million | 358.34 Million |
| Capital Expenditure | -958 Thousand | -3.94 Million | -229 Thousand | -608 Thousand | -208 Thousand | -510 Thousand |
| Effect of forex changes on cash | - | - | -746 Thousand | 1.56 Million | -173 Thousand | -33 Thousand |
| Net cash flow / Change in cash | -893.24 Million | -381.8 Million | 314.92 Million | 1.74 Billion | -265.57 Million | -217.01 Million |
| Free Cash Flow | 256.01 Million | 198.06 Million | 929.44 Million | 64.16 Million | 15.87 Million | 744.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 158.86 Million | 102.74 Million | 37.37 Million | 274.65 Million | 103.06 Million | 72.21 Million |
| Depreciation & Amortization | 2.32 Million | 2.28 Million | 2.26 Million | 9.02 Million | 2.25 Million | 2.25 Million |
| Deferred income taxes | - | - | -1.28 Million | -16.75 Million | -44.8 Million | 5.96 Million |
| Stock-based compensation | 463 Thousand | 463 Thousand | 422 Thousand | 3.38 Million | 677 Thousand | 950 Thousand |
| Change in working capital | -18.22 Million | -6.27 Million | 24.88 Million | 8.76 Million | -52.15 Million | 28.62 Million |
| Other non-cash items | 69.08 Million | -15.97 Million | 11.52 Million | -22.08 Million | -14.4 Million | -13.2 Million |
| Investing Cash Flow | 175.11 Million | -18.22 Million | -934.94 Million | -855.48 Million | 23.15 Million | -33.8 Million |
| Investments in PPE | -398 Thousand | -913 Thousand | -580 Thousand | -958 Thousand | -206 Thousand | 40 Thousand |
| Acquisitions | - | - | 374 Thousand | - | - | - |
| Investment purchases | -286.9 Million | -209.97 Million | -1.29 Billion | -1.73 Billion | -145.73 Million | -206.52 Million |
| Sales/Maturities of investments | 462.41 Million | 192.11 Million | 359.53 Million | 880.21 Million | 169.26 Million | 172.72 Million |
| Other Investing Activities | 175.51 Million | 546 Thousand | -374 Thousand | -40 Thousand | -172 Thousand | -40 Thousand |
| Financing Cash Flow | -1.91 Million | -1.9 Million | -1.89 Million | -294.73 Million | -289.08 Million | -1.88 Million |
| Debt repayment | -1.91 Million | -1.9 Million | -1.89 Million | -7.53 Million | -1.88 Million | -1.88 Million |
| Dividends payments | - | - | - | -287.19 Million | -287.19 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.91 Million | - | - | -7.53 Million | -1.88 Million | -1.88 Million |
| Accounts receivables | -15.27 Million | -6.68 Million | -7.52 Million | -13.8 Million | -4.39 Million | 699 Thousand |
| Accounts payables | -30.39 Million | 30.39 Million | - | - | 4.39 Million | -699 Thousand |
| Inventory | 11.82 Million | -17.96 Million | 11.17 Million | 18.47 Million | 11.75 Million | -18.2 Million |
| Other working capital | 15.62 Million | -12.02 Million | 21.23 Million | 4.09 Million | -63.91 Million | 46.83 Million |
| Cash at beginning of period | 939.98 Million | 875.61 Million | 1.73 Billion | 1.76 Billion | 2 Billion | 1.94 Billion |
| Cash at end of period | 1.28 Billion | 939.98 Million | 875.61 Million | 875.61 Million | 1.73 Billion | 2 Billion |
| Capital Expenditure | -398 Thousand | -913 Thousand | -580 Thousand | -958 Thousand | -206 Thousand | 40 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 346.75 Million | 64.36 Million | -861.66 Million | -893.24 Million | -271.3 Million | 61.1 Million |
| Free Cash Flow | 173.16 Million | 83.58 Million | 74.59 Million | 256.01 Million | -5.58 Million | 96.83 Million |
FUTS
1626
600052
600851
5302
SYSX